Asgard Therapeutics and its founders were featured as the example spin-off from Lund University 

Posted 7 September, 2022

Asgard Therapeutics, founded by CEO Cristiana Pires, Head of Research Fábio Fiúza Rosa, and Head of Innovation Filipe Pereira, exemplifies a successful spin-off from Lund University. They took their innovative research within cancer immunotherapy all the way from the academic setup to the creation of the company that raised EUR 6M for its development.